Advanced SearchSearch Tips
Epigenetic silencing of olfactomedin-4 enhances gastric cancer cell invasion via activation of focal adhesion kinase signaling
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
  • Journal title : BMB Reports
  • Volume 48, Issue 11,  2015, pp.630-635
  • Publisher : Korean Society for Biochemistry and Molecular Biology
  • DOI : 10.5483/BMBRep.2015.48.11.130
 Title & Authors
Epigenetic silencing of olfactomedin-4 enhances gastric cancer cell invasion via activation of focal adhesion kinase signaling
Guo, Li-Li; He, Zhao-Cai; Yang, Chang-Qing; Qiao, Pei-Tang; Yin, Guo-Ling;
  PDF(new window)
Downregulation of olfactomedin-4 (OLFM4) is associated with tumor progression, lymph node invasion and metastases. However, whether or not downregulation of OLFM4 is associated with epigenetic silencing remains unknown. In this study, we investigate the role of OLFM4 in gastric cancer cell invasion. We confirm the previous result that OLFM4 expression is increased in gastric cancer tissues and decreases with an increasing number of metastatic lymph nodes, which are associated with OLFM4 promoter hypermethylation. Overexpression of OLFM4 in gastric cancer cells had an inhibitory effect on cell invasion. Furthermore, we found that focal adhesion kinase (FAK) was negatively correlated with OLFM4 in regards to lymph node metastasis in gastric cancer tissues. Also, inhibition of FAK induced by OLFM4 knockdown resulted in a decrease in cell invasion. Thus, our study demonstrates that epigenetic silencing of OLFM4 enhances gastric cancer cell invasion via activation of FAK signaling.
Focal adhesion kinase;Gastric cancer;Invasion;Matrix metalloproteinases;Metastasis;Olfactomedin-4;
 Cited by
Loss of OLFM4 promotes tumor migration through inducing interleukin-8 expression and predicts lymph node metastasis in early gastric cancer, Oncogenesis, 2016, 5, 6, e234  crossref(new windwow)
The clinical significance and biological function of olfactomedin 4 in triple negative breast cancer, Biomedicine & Pharmacotherapy, 2017, 86, 67  crossref(new windwow)
Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update, Open Biology, 2017, 7, 9, 170152  crossref(new windwow)
A unified model of the hierarchical and stochastic theories of gastric cancer, British Journal of Cancer, 2017, 116, 8, 973  crossref(new windwow)
Clemmensen SN, Bohr CT, Rorvig S et al (2012) Olfactomedin 4 defines a subset of human neutrophils. J Leukoc Biol 91, 495-500 crossref(new window)

Chin KL, Aerbajinai W, Zhu J et al (2008) The regulation of OLFM4 expression in myeloid precursor cells relies on NF-kappaB transcription factor. Br J Haematol 143, 421-432 crossref(new window)

Sun F, Peatman E, Li C et al (2012) Transcriptomic signatures of attachment, NF-kappaB suppression and IFN stimulation in the catfish gill following columnaris bacterial infection. Dev Comp Immunol 38, 169-180 crossref(new window)

Grover PK, Hardingham JE, Cummins AG (2010) Stem cell marker olfactomedin 4: critical appraisal of its characteristics and role in tumorigenesis. Cancer Metastasis Rev 29, 761-775 crossref(new window)

Besson D, Pavageau AH, Valo I et al (2011) A quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor marker. Mol Cell Proteomics 10, M111-M9712 crossref(new window)

Yu L, Wang L, Chen S (2011) Olfactomedin 4, a novel marker for the differentiation and progression of gastrointestinal cancers. Neoplasma 58, 9-13 crossref(new window)

Sampieri CL, Leon-Cordoba K, Remes-Troche JM (2013) Matrix metalloproteinases and their tissue inhibitors in gastric cancer as molecular markers. J Cancer Res Ther 9, 356-363 crossref(new window)

Jang BG, Lee BL, Kim WH (2015) Olfactomedin-related proteins 4 (OLFM4) expression is involved in early gastric carcinogenesis and of prognostic significance in advanced gastric cancer. Virchows Arch 467, 285-294 crossref(new window)

Luo Z, Zhang Q, Zhao Z, Li B, Chen J, Wang Y (2011) OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer. J Cancer Res Clin Oncol 137, 1713-1720 crossref(new window)

Yamanoi K, Arai E, Tian Y et al (2015) Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome. Carcinogenesis 36, 509-520 crossref(new window)

Carneiro P, Figueiredo J, Bordeira-Carrico R et al (2013) Therapeutic targets associated to E-cadherin dysfunction in gastric cancer. Expert Opin Ther Targets 17, 1187-1201 crossref(new window)

Koshida S, Kobayashi D, Moriai R, Tsuji N, Watanabe N (2007) Specific overexpression of OLFM4(GW112/HGC-1) mRNA in colon, breast and lung cancer tissues detected using quantitative analysis. Cancer Sci 98, 315-320 crossref(new window)

Liu W, Zhu J, Cao L, Rodgers GP (2007) Expression of hGC-1 is correlated with differentiation of gastric carcinoma. Histopathology 51, 157-165 crossref(new window)

Oue N, Sentani K, Noguchi T et al (2009) Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer 125, 2383-2392 crossref(new window)

Suh YS, Lee HJ, Jung EJ et al (2012) The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer. Ann Surg Oncol 19, 1240-1249 crossref(new window)

He D, Zhang YW, Zhang NN et al (2015) Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas. Med Oncol 32, 92 crossref(new window)

Zouridis H, Deng N, Ivanova T et al (2012) Methylation subtypes and large-scale epigenetic alterations in gastric cancer. Sci Transl Med 4, 140r-156r crossref(new window)

Dauksa A, Gulbinas A, Endzinas Z, Oldenburg J, El-Maarri O (2014) DNA methylation at selected CpG sites in peripheral blood leukocytes is predictive of gastric cancer. Anticancer Res 34, 5381-5388

Zhao C, Bu X (2012) Promoter methylation of tumor-related genes in gastric carcinogenesis. Histol Histopathol 27, 1271-1282

Du T, Qu Y, Li J et al (2014) Maternal embryonic leucine zipper kinase enhances gastric cancer progression via the FAK/Paxillin pathway. Mol Cancer 13, 100 crossref(new window)

Roberts WG, Ung E, Whalen P et al (2008) Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Cancer Res 68, 1935-1944 crossref(new window)

Mon NN, Ito S, Senga T, Hamaguchi M (2006) FAK signaling in neoplastic disorders: a linkage between inflammation and cancer. Ann N Y Acad Sci 1086, 199-212 crossref(new window)

Zhang J, Liu WL, Tang DC et al (2002) Identification and characterization of a novel member of olfactomedin-related protein family, hGC-1, expressed during myeloid lineage development. Gene 283, 83-93 crossref(new window)

Park KS, Kim KK, Piao ZH et al (2012) Olfactomedin 4 suppresses tumor growth and metastasis of mouse melanoma cells through downregulation of integrin and MMP genes. Mol Cells 34, 555-561 crossref(new window)

Liu RH, Yang MH, Xiang H et al (2012) Depletion of OLFM4 gene inhibits cell growth and increases sensitization to hydrogen peroxide and tumor necrosis factor-alpha induced-apoptosis in gastric cancer cells. J Biomed Sci 19, 38 crossref(new window)